期刊
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
卷 107, 期 3, 页码 758-767出版社
WILEY-BLACKWELL
DOI: 10.1111/j.1742-7843.2010.00573.x
关键词
-
资金
- Osterreichische Forschungsforderungsgesellschaft mbH [DA2005-01-187]
- Austrian Research Promotion Agency [805 419]
Pyrrolidine dithiocarbamate (PDTC) was examined for its potential in the intranasal treatment of human rhinovirus infections. Prior to clinical testing, a comprehensive non-clinical programme was performed to evaluate the general toxicity of PDTC. The animal experiments included investigations in rodents with study durations ranging from single dose to repeated dosing over a period of 28 days. The routes of administration were intranasal, inhalative, oral and intravenous for single-dose toxicity and pharmacokinetic studies, and intranasal for repeated dose studies. Blood and tissue samples were obtained from PDTC-treated rats to analyse pharmacokinetics and tissue distribution. Accumulation of selected metals due to PDTC treatment was examined in liver, brain, nerves and fat tissues.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据